NCT02497872

Brief Summary

BACKGROUND: The most common complication of endoscopic retrograde cholangiopancreatography (ERCP) is pancreatitis. Precut sphincterotomy has been regarded as a risk factor. However, early precut may actually reduce post-ERCP pancreatitis risk. However, early precut as a preventive measure has not been compared to other preventive measures, such as pancreatic duct stent placement. AIM: To compare the efficacy of early precut sphincterotomy versus pancreatic duct stent placement in high-risk subjects undergoing ERCP. MATERIALS AND METHODS: This is a single-blinded, randomized trial that took place in two tertiary referral centers in Buenos Aires. ERCP subjects shall present at least one of the following risk factors: female sex, age less than 40 years, clinical suspicion of Sphincter of Oddi dysfunction, previous pancreatitis, common bile duct diameter of less than 8 mm. Only those who present a difficult biliary cannulation shall be randomized into two groups: those who receive early precut sphincterotomy or those in whom persistency of biliary cannulation is intended with subsequent pancreatic duct stent placement after cholangiography is achieved. The incidence of post-ERCP pancreatitis as well as other complications shall be compared.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2011

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

May 29, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 15, 2015

Completed
Last Updated

July 15, 2015

Status Verified

July 1, 2015

Enrollment Period

2.1 years

First QC Date

May 29, 2015

Last Update Submit

July 12, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Post-ERCP Pancreatitis

    48 hours

Study Arms (2)

Early Precut Sphincterectomy

EXPERIMENTAL

Biliary stone removal using early precut: Patients enrolled in this arm received biliary drainage through a small incision on the papilla with an endoscopic needle-knife - a technique called precut sphincterotomy.

Procedure: Biliary stone removal

Pancreatic Duct Stent

ACTIVE COMPARATOR

Biliary stone removal using persistence of cannulation and a later pancreatic duct stent placement: Patients enrolled in this arm received conventional biliary drainage through persistent biliary cannulation. After completion of biliary drainage, a prophylactic pancreatic duct stent was placed.

Procedure: Biliary stone removal

Interventions

Biliary stones are removed from the common bile duct by means of a sphincterotomy performed by standardized endoscopic retrograde cholangiopancreatography

Early Precut SphincterectomyPancreatic Duct Stent

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects with in need for ERCP due to benign or malignant biliopancreatic conditions, with at least one of the following features:
  • female sex
  • age less than 40 years
  • clinical suspicion of Sphincter of Oddi Dysfunction
  • previous pancreatitis
  • common bile duct diameter of less than 8 mm
  • Subjects with difficult biliary cannulation, as defined by previously published criteria

You may not qualify if:

  • patients with contrast allergy
  • pregnant women
  • patients unable to sign informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

May 29, 2015

First Posted

July 15, 2015

Study Start

November 1, 2011

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

July 15, 2015

Record last verified: 2015-07